CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

2.311 +0.041 (+1.81%)

Streaming Delayed Price Updated: 3:46 PM EDT, May 1, 2026 Add to My Watchlist

Price and Volume

Volume	12,377
Open	2.270
Bid (Size)	2.240 (100)
Ask (Size)	2.410 (1,000)
Prev. Close	2.270
Today's Range	2.270 - 2.370
52wk Range	1.900 - 34.80
Shares Outstanding	620,290
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Study Finds Exercise, Ibuprofen Combat Brain Fog in Cancer Patients

April 28, 2026

Via Investor Brand Network

New Molecule May Open New Therapeutic Pathway Against Brain Cancer

April 27, 2026

Via Investor Brand Network

Performance

YTD	-56.4%	-56.4%
1 Month	+1.6%	+1.6%
3 Month	-58.6%	-58.6%
6 Month	-70.0%	-70.0%
1 Year	-81.8%	-81.8%

More News

Why Molecular Testing is Increasingly Important in CNS Cancers

April 21, 2026

Via Investor Brand Network

Scientists Discover Brain Cells That Aid Brain Cancer Development

April 15, 2026

Via Investor Brand Network

Preclinical Study Reveals Promising Treatment for Glioblastoma

April 14, 2026

Via Investor Brand Network

Study Explores Whether a Common Vitamin Could Fight Brain Cancer

April 07, 2026

Via Investor Brand Network

Researchers Solve 50-Year-Old Challenge in Making Cancer Drug

April 01, 2026

Via Investor Brand Network

Researchers Discover Mechanism Behind Deadly Pediatric Brain Cancer

March 31, 2026

Via Investor Brand Network

Misinformation Could Thwart the Potential of Cancer Vaccines

March 24, 2026

Via Investor Brand Network

Fewer Men Undergo Cancer Screening, Study Shows

March 23, 2026

Via Investor Brand Network

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

March 17, 2026

Via Investor Brand Network

Researchers Trace Differing Pediatric Brain Tumors to Common Source

March 11, 2026

Via Investor Brand Network

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Launches New Growth Strategy Focused On Neurology And Oncology Pipeline Expansion

March 11, 2026

Via Investor Brand Network

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

March 11, 2026

Via ACCESS Newswire

New Research Challenges Current Thinking on How Brain Cancer Develops

March 10, 2026

Via Investor Brand Network

New Treatment Dramatically Improves Survival for Patients with Deadly Brain Tumors

March 03, 2026

Via Investor Brand Network

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer

March 02, 2026

Via Investor Brand Network

New Study Unveils Promising Way to Conduct Brain Surgery Against Cancer

March 02, 2026

Via Investor Brand Network

CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

March 02, 2026

Via ACCESS Newswire

American Science Suffers as Brain Drain Intensifies

February 24, 2026

Via Investor Brand Network

Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds

February 18, 2026

Via Investor Brand Network

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team

February 17, 2026

Via Investor Brand Network

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

February 17, 2026

Via ACCESS Newswire

Groundbreaking Study Uncovers Why Breast Cancer Metastasizes to the Brain

February 13, 2026

Via Investor Brand Network

New AI Model Predicts Dementia Risk, Cancer Survival and Brain Age

February 11, 2026

Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?

CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market

What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?

The current price of CNS Pharmaceuticals, Inc. - Common Stock is 2.311

When was CNS Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 05/01/26 03:46 PM ET

What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?

The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 1.43M

How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?

CNS Pharmaceuticals, Inc. - Common Stock has 1M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.